207 related articles for article (PubMed ID: 10952683)
1. Pharmacological characterization of [(3)H]-prostaglandin E(2) binding to the cloned human EP(4) prostanoid receptor.
Davis TL; Sharif NA
Br J Pharmacol; 2000 Aug; 130(8):1919-26. PubMed ID: 10952683
[TBL] [Abstract][Full Text] [Related]
2. Cloned human EP1 prostanoid receptor pharmacology characterized using radioligand binding techniques.
Sharif NA; Davis TL
J Pharm Pharmacol; 2002 Apr; 54(4):539-47. PubMed ID: 11999132
[TBL] [Abstract][Full Text] [Related]
3. Affinities, selectivities, potencies, and intrinsic activities of natural and synthetic prostanoids using endogenous receptors: focus on DP class prostanoids.
Sharif NA; Crider JY; Xu SX; Williams GW
J Pharmacol Exp Ther; 2000 May; 293(2):321-8. PubMed ID: 10772998
[TBL] [Abstract][Full Text] [Related]
4. In vitro pharmacological characterization of CJ-042794, a novel, potent, and selective prostaglandin EP(4) receptor antagonist.
Murase A; Taniguchi Y; Tonai-Kachi H; Nakao K; Takada J
Life Sci; 2008 Jan; 82(3-4):226-32. PubMed ID: 18155068
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological characterization and identification of EP3 prostanoid receptor binding sites in hamster uterus homogenates.
Sharif NA; Xu SX
J Pharm Pharmacol; 2004 Feb; 56(2):197-203. PubMed ID: 15005878
[TBL] [Abstract][Full Text] [Related]
6. Piglet saphenous vein contains multiple relaxatory prostanoid receptors: evidence for EP4, EP2, DP and IP receptor subtypes.
Wilson RJ; Giles H
Br J Pharmacol; 2005 Feb; 144(3):405-15. PubMed ID: 15655509
[TBL] [Abstract][Full Text] [Related]
7. EP4 prostanoid receptor-mediated vasodilatation of human middle cerebral arteries.
Davis RJ; Murdoch CE; Ali M; Purbrick S; Ravid R; Baxter GS; Tilford N; Sheldrick RL; Clark KL; Coleman RA
Br J Pharmacol; 2004 Feb; 141(4):580-5. PubMed ID: 14744815
[TBL] [Abstract][Full Text] [Related]
8. Prostaglandin E(2) couples through EP(4) prostanoid receptors to induce IL-8 production in human colonic epithelial cell lines.
Dey I; Giembycz MA; Chadee K
Br J Pharmacol; 2009 Feb; 156(3):475-85. PubMed ID: 19175605
[TBL] [Abstract][Full Text] [Related]
9. Prostanoid EP(1)- and TP-receptors involved in the contraction of human pulmonary veins.
Walch L; de Montpreville V; Brink C; Norel X
Br J Pharmacol; 2001 Dec; 134(8):1671-8. PubMed ID: 11739243
[TBL] [Abstract][Full Text] [Related]
10. Key structural features of prostaglandin E(2) and prostanoid analogs involved in binding and activation of the human EP(1) prostanoid receptor.
Ungrin MD; Carrière MC; Denis D; Lamontagne S; Sawyer N; Stocco R; Tremblay N; Metters KM; Abramovitz M
Mol Pharmacol; 2001 Jun; 59(6):1446-56. PubMed ID: 11353805
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the recombinant human prostanoid DP receptor and identification of L-644,698, a novel selective DP agonist.
Wright DH; Metters KM; Abramovitz M; Ford-Hutchinson AW
Br J Pharmacol; 1998 Apr; 123(7):1317-24. PubMed ID: 9579725
[TBL] [Abstract][Full Text] [Related]
12. 8-iso-PGE2 stimulates anion efflux from airway epithelial cells via the EP4 prostanoid receptor.
Joy AP; Cowley EA
Am J Respir Cell Mol Biol; 2008 Feb; 38(2):143-52. PubMed ID: 17690331
[TBL] [Abstract][Full Text] [Related]
13. E-ring 8-isoprostanes inhibit ACh release from parasympathetic nerves innervating guinea-pig trachea through agonism of prostanoid receptors of the EP3-subtype.
Clarke DL; Giembycz MA; Patel HJ; Belvisi MG
Br J Pharmacol; 2004 Feb; 141(4):600-9. PubMed ID: 14744812
[TBL] [Abstract][Full Text] [Related]
14. Phosphorylation of glycogen synthase kinase-3 and stimulation of T-cell factor signaling following activation of EP2 and EP4 prostanoid receptors by prostaglandin E2.
Fujino H; West KA; Regan JW
J Biol Chem; 2002 Jan; 277(4):2614-9. PubMed ID: 11706038
[TBL] [Abstract][Full Text] [Related]
15. Stimulation of renin release by prostaglandin E2 is mediated by EP2 and EP4 receptors in mouse kidneys.
Schweda F; Klar J; Narumiya S; Nüsing RM; Kurtz A
Am J Physiol Renal Physiol; 2004 Sep; 287(3):F427-33. PubMed ID: 15113745
[TBL] [Abstract][Full Text] [Related]
16. Characterization of ep prostanoid receptor subtypes in primary cultures of bovine ciliary epithelial cells by immunofluorescent microscopy and functional studies.
Anthony TL; Pierce KL; Regan JW
Curr Eye Res; 2000 May; 20(5):394-404. PubMed ID: 10855034
[TBL] [Abstract][Full Text] [Related]
17. Replacement of the carboxylic acid group of prostaglandin f(2alpha) with a hydroxyl or methoxy substituent provides biologically unique compounds.
Woodward DF; Krauss AH; Chen J; Gil DW; Kedzie KM; Protzman CE; Shi L; Chen R; Krauss HA; Bogardus A; Dinh HT; Wheeler LA; Andrews SW; Burk RM; Gac T; Roof MB; Garst ME; Kaplan LJ; Sachs G; Pierce KL; Regan JW; Ross RA; Chan MF
Br J Pharmacol; 2000 Aug; 130(8):1933-43. PubMed ID: 10952685
[TBL] [Abstract][Full Text] [Related]
18. Prostaglandin E₂ induced contraction of human intercostal arteries is mediated by the EP₃ receptor.
Longrois D; Gomez I; Foudi N; Topal G; Dhaouadi M; Kotelevets L; Chastre E; Norel X
Eur J Pharmacol; 2012 Apr; 681(1-3):55-9. PubMed ID: 22342278
[TBL] [Abstract][Full Text] [Related]
19. Molecular cloning and characterization of the four rat prostaglandin E2 prostanoid receptor subtypes.
Boie Y; Stocco R; Sawyer N; Slipetz DM; Ungrin MD; Neuschäfer-Rube F; Püschel GP; Metters KM; Abramovitz M
Eur J Pharmacol; 1997 Dec; 340(2-3):227-41. PubMed ID: 9537820
[TBL] [Abstract][Full Text] [Related]
20. Functional pharmacology of human prostanoid EP2 and EP4 receptors.
Wilson RJ; Rhodes SA; Wood RL; Shield VJ; Noel LS; Gray DW; Giles H
Eur J Pharmacol; 2004 Oct; 501(1-3):49-58. PubMed ID: 15464062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
